Opening book details…
About this Medicine article
Sorafenib and Sunitinib, Two Anticancer Drugs, Inhibit CYP3A4-Mediated and Activate CY3A5-Mediated Midazolam 1'-Hydroxylation by Sugiyama, M.; Fujita, K.-i.; Murayama, N.; Akiyama, Y.; Yamazaki, H.; Sasaki, Y. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Sugiyama, M.; Fujita, K.-i.; Murayama, N.; Akiyama, Y.; Yamazaki, H.; Sasaki, Y.
- Publisher
- American Society for Pharmacology and Experimental Therapeutics; American Society for Pharmacology & Experimental Therapeutics; American Society for Pharmacology & Experimental Therapeutics (ASPET) (ISSN 0090-9556)
- Published
- 2011
- Language
- EN
- Field
- Medicine (Life Sciences)
More by Sugiyama, M.; Fujita, K.-i.; Murayama, N.; Akiyama, Y.; Yamazaki, H.; Sasaki, Y.
Browse all works by Sugiyama, M.; Fujita, K.-i.; Murayama, N.; Akiyama, Y.; Yamazaki, H.; Sasaki, Y.